A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV
Status:
Terminated
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Because drugs used to treat TB can reduce the amount of the anti-HIV drugs that reach the
sites where the virus is located, this study is designed to see whether it is necessary to
use higher doses of antiviral (anti-HIV) drugs while patients are receiving therapy with
rifampin, one of the drugs commonly used to treat TB. Participants will be assigned to one of
4 arms (see below) and will be followed during the time when they are receiving both
treatments.